Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Average Recommendation of “Buy” by Analysts

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY) have earned a consensus rating of “Buy” from the seven research firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and three have given a strong buy recommendation to the company.

Several brokerages have weighed in on RBGLY. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th. Barclays cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 4th. HSBC upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Finally, Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th.

Reckitt Benckiser Group Trading Down 0.7 %

Shares of Reckitt Benckiser Group stock opened at $13.37 on Thursday. Reckitt Benckiser Group has a twelve month low of $10.24 and a twelve month high of $14.90. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. The company has a 50-day simple moving average of $12.62 and a two-hundred day simple moving average of $12.27.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.